A retrospective study of 17 COVID-19 survivors with lingering symptoms reveals that 10 (59%) had nerve damage, which the researchers said could have been triggered by potentially treatable infection-related immune dysfunction.
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
Implementation of a test that provides rapid bacterial identification and susceptibility results from positive blood cultures shortened the time to optimal antibiotic therapy and reduced unnecessary antibiotic exposure in hospitalized patients with bacteremia, researchers reported late last week in the Journal of Antimicrobial Chemotherapy.
The US Centers for Disease Control and Prevention (CDC) announced yesterday that the Pan American Health Organization (PAHO)/World Health Organization (WHO) have designated the CDC's Center for Global Health as a PAHO/WHO Collaborating Center for Biosafety and Biosecurity.
The National Institutes of Health (NIH) yesterday announced that researchers have started enrolling participants in a phase 1 clinical trial to evaluate immunogenicity and safety of two licensed seasonal flu vaccines given with and without novel adjuvants.
The Democratic Republic of the Congo (DRC) saw no let-up in Ebola cases over the weekend, reporting 39 new cases, which would boost the outbreak total to 2,763, according to updates from the World Health Organization (WHO) online Ebola dashboard.
Based on data reported for Aug 2, the DRC reported 17 more cases, and for Aug 3 the country reported 12 more infections.
The World Health Organization (WHO) European regional office said yesterday that the region achieved 91% coverage for the second dose of measles vaccine, signifying the second consecutive year that the area has reached a record high.
Saudi Arabia's Ministry of Health (MOH) reported a new MERS-CoV case today in the city of Jeddah. The notice came in an epidemiologic week 20 notification.
The patient is a 73-year-old man. The source of his MERS-CoV (Middle East respiratory syndrome coronavirus) infection is listed as "primary," meaning it is unlikely he contracted the virus from another person. He did, however, have recent contact with camels.
The DoD has made only 18 of 35 proposed changes designed to enhance lab security, the report says.